Showing results (281-290 of 293) with videos related to

Sort By:
Pageof 30
Annals of the Rheumatic Diseases|November 23, 2012
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditionsJosef S Smolen, Monika M Schoels, Norihiro Nishimoto, et al.
Arthritis and Rheumatism|September 28, 2010
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeDaniel Aletaha, Tuhina Neogi, Alan J Silman, et al.
Annals of the Rheumatic Diseases|August 12, 2010
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeDaniel Aletaha, Tuhina Neogi, Alan J Silman, et al.
Journal of Translational Autoimmunity|January 1, 2024
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE studyChiara Tani, Chiara Cardelli, Roberto Depascale, et al.
Arthritis and Rheumatism|September 28, 2010
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological reportTuhina Neogi, Daniel Aletaha, Alan J Silman, et al.
Annals of the Rheumatic Diseases|March 18, 2024
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 updateLaure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, et al.
Annals of the Rheumatic Diseases|May 14, 2015
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceJosef S Smolen, Ferdinand C Breedveld, Gerd R Burmester, et al.
Clinical and Experimental Rheumatology|March 14, 2023
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody productsRosaria Talarico, Giuseppe Alvise Ramirez, Sofia C Barreira, et al.
Annals of the Rheumatic Diseases|January 24, 2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, et al.
Annals of the Rheumatic Diseases|March 13, 2026
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 updateJosef S Smolen, Christopher J Edwards, Victoria Konzett, et al.
Pageof 30